LUYE PHARMA GROUP LIMITED revenue for the last year amounted to 6.76 B HKD, the most of which — 2.68 B HKD — came from its highest performing source at the moment, Oncology Drugs, the year earlier bringing 1.70 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought LUYE PHARMA GROUP LIMITED 5.85 B HKD, and the year before that — 5.11 B HKD.